BioMarin Pharmaceutical Inc. (BVMF:B1MR34)
Brazil · Delayed Price · Currency is BRL 145.04
-1.38 (-0.94%)
At close: Dec 2, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 54.82 billion as of December 4, 2025. Its market cap has decreased by -19.22% in one year.
Market Cap
54.82B
Enterprise Value
50.19B
Revenue
16.49B
Ranking
n/a
PE Ratio
19.76
Stock Price
145.04
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 813.63M to 54.82B, an increase of 6,637.49%. That is a compound annual growth rate of 17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 54.82B | -29.25% |
| Dec 31, 2024 | 77.48B | -12.09% |
| Dec 29, 2023 | 88.13B | -13.33% |
| Dec 30, 2022 | 101.68B | 12.51% |
| Dec 31, 2021 | 90.38B | 9.32% |
| Dec 31, 2020 | 82.67B | 35.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.37B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |